comparemela.com

Latest Breaking News On - Mahendra rao - Page 2 : comparemela.com

Startup news and updates: daily roundup (April 26, 2023)

YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here's the roundup for Wednesday, April 26, 2023.

United statesRameswar misraMahendra raoDeepesh agarwalJitendra guptaSaumitra kumarNavin talrejaNeobank jupiterPrateek indwarAmarpreet singh anandBhupinder singhPrabhjeet singhAjay jainViiveck vermaSears holding corporationsCentre for regenerative medicine

Bengaluru-based biotech startup Nkure raises pre–Series A round

Pioneering affordable NK cell therapy for the treatment of cancer

United statesMahendra raoDepartment of biotechnologyCentre for regenerative medicineCentre for cellularOnkure therapeuticsEndiya partnersKotak investment advisorsFounding directorRegenerative medicineMolecular platformsCell therapy

Pluristyx and panCELLa Expand Intellectual Property Portfolio for Pluripotent Stem Cell Cloaking Technology

panCELLa granted patent in the United Kingdom for induced Allogeneic Cell Tolerance (iACT Stealth) Technology Pluristyx and panCELLa today are excited to announce the granting of a patent used in

United kingdomGreat britainJake krembilCellaa pluristyxMahendra raoBrian hawkinsArmand keatingAndras nagyKostenloser wertpapierhandelBenjamin fryerStealth technologyGreat britain patent office onSinai health systemAllogeneic cell toleranceGreat britain patent officeMount sinai hospital

Investegate |Kadimastem Announcements | Kadimastem: Kadimastem and Implant Therapeutics, Inc Sign an Evaluation Agreement Towards the Potential Licensing of Immune Evasive Cells

Investegate announcements from Kadimastem, Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of “Immune Evasive” Cells

Tel avivAsaf shiloniMahendra raoKadimastem isletrxCompany websiteTherapeutics incKadimastem ltdWeizmann institute of scienceTel aviv stock exchangeMust have communicationsImplant therapeuticsImplant therapeuticHuman embryonic stem cellsProfessor michel revelProfessor emeritusMolecular genetics

DGAP-News: Kadimastem and Implant Therapeutics, Inc Sign an Evaluation Agreement Towards the Potential Licensing of Immune Evasive Cells

DGAP-News: Kadimastem Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of "Immune Evasive" Cells 08.06.2022 / 13:00 The issuer

United statesTel avivAsaf shiloniMahendra raoKadimastem isletrxKadimastem ltdWeizmann institute of scienceDistribution servicesTherapeutics incNews serviceTel aviv stock exchangeMust have communicationsImplant therapeuticsEvaluation agreement towardsPotential licensingImplant therapeutic

vimarsana © 2020. All Rights Reserved.